Antonio Matrone

34PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 12, 2026
18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response.

|Mar 27, 2026
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.

Elisa Minaldi, Teresa Ramone, Raffaele Ciampi

|Feb 25, 2026
Fatal tracheal perforation following Dabrafenib-Trametinib therapy in <i>BRAF</i> V600E-mutant mixed anaplastic thyroid cancer.

Antonio Matrone, Marianna Scordo, Elisa Minaldi

|Feb 14, 2026
Calcitonin thresholds for prediction of medullary thyroid carcinoma and its clinical response in MEN2A gene carriers.

Alessandro Prete, Antonio Matrone, Cristina Romei

|Mar 28, 2025
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series.

Alessandro Prete, Carla Gambale, Valeria Bottici

|Mar 10, 2025
Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Laura Valerio, Antonio Matrone

Pageof 6

Frequent Collaborators

23 joint publications

Rossella Elisei

7 joint publications

Alessandro Prete

7 joint publications

Cristina Romei

6 joint publications

Raffaele Ciampi